Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000914208-17-000090
Filing Date
2017-02-01
Accepted
2017-02-01 14:58:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 SEC SCHEDULE 13G SEC13G_Filing.htm SC 13G/A 16480
  Complete submission text file 0000914208-17-000090.txt   18347
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Subject) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-38071 | Film No.: 17564505
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1555 PEACHTREE STREET NE SUITE 1800 ATLANTA GA 30309
Business Address 1555 PEACHTREE STREET NE SUITE 1800 ATLANTA GA 30309 404-892-0896
Invesco Ltd. (Filed by) CIK: 0000914208 (see all company filings)

EIN.: 980557567 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice